Healthcare Pharmaceutical Biotech

Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

September 28, 2026 6:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced the completion of patient enrollment in the MEND-PNPO Phase 3 study (ClinicalTrials.gov NCT04706013), a pivotal trial evaluating MC-1 for the treatment of Pyridox(am)ine 5'-Phosphate Oxidase (PNPO)...

Read more

Allstar Health Brands Acquires 60% of Future Girls Soccer Academy

September 28, 2026 3:55 PM

Allstar Health Brands Inc. today announced that it has finalized an agreement to acquire a 60 percent ownership stake in Future Girls Soccer Academy, an exclusive academy dedicated to preparing young athletes for professional play. The acquisition is the first step in a comprehensive North American expansion of the Future Girls model, with Miami, Florida confirmed as the first new market, followed by additional locations across the United States...

Read more

Dr. Carlos E. Sanchez Joins Faculty for EVOQUE Tricuspid Valve Replacement and ICE Program at Piedmont Atlanta Hospital

September 28, 2026 1:17 PM

Interventional cardiologist Carlos E. Sanchez, MD, will serve as faculty for an advanced structural heart education program at Piedmont Atlanta Hospital on September 28-29, 2026, focused on transcatheter tricuspid valve replacement (TTVR) with the EVOQUE system and the use of intracardiac echocardiography (ICE) to guide the procedure. Dr. Sanchez was invited to share his clinical experience with the adoption of 3D ICE for structural heart...

Read more

Dr. Sean Doherty Offers Motiva(R) Implants for Breast Augmentation in Boston

September 28, 2026 1:00 PM

Board-certified plastic surgeon Dr. Sean Doherty now offers Motiva® Preservé breast augmentation at his Boston and Chestnut Hill offices. The procedure pairs Motiva® implants with a set of instruments that create the implant pocket by separating breast tissue rather than cutting it, and it can be performed under sedation or local anesthesia. Breast augmentation has been among the most requested aesthetic surgical procedures for decades, but the...

Read more

Q&A with Bhavitha Guntupalli: Building the Future of Data Integration in Healthcare and Beyond

September 28, 2026 12:45 PM

As organizations increasingly rely on data to drive digital transformation, professionals like Bhavitha Guntupalli are helping design modern data ecosystems that improve analytics, operational efficiency, and informed decision-making. With over a decade of experience spanning healthcare, finance, and enterprise data systems, Bhavitha's career reflects a commitment to innovation, continuous learning, and building scalable data solutions that...

Read more

Dr. Joanna Kam Explains Why Some Facial Concerns Go Deeper Than the Skin

September 28, 2026 12:15 PM

Dr. Joanna Kam, a board-certified otolaryngologist and fellowship-trained facial plastic surgeon, is sharing her perspective on a question many patients bring to her office: why a feature still bothers them after years of skincare, injectables, and other surface-level treatments. Her answer is that the skin is often not the source of the concern. In many cases, the underlying bone and cartilage determine what a person sees, and addressing those...

Read more

From Caregiver to Engineer

September 28, 2026 11:30 AM

When Shawn Wei was 9 years old, hospitals became a regular part of his life. His father was receiving throat cancer care at Kaiser Oakland Medical Center in California, and Wei spent hours in waiting rooms and hallways. He was drawn to the medical equipment around him. Today, that curiosity has grown into a passion for healthcare technology. This fall, Wei, a recent high school graduate from Berkeley, California, will begin studying Mechanical...

Read more

What is the Best Online Course for Fillers?

September 28, 2026 10:00 AM

The American Academy of Cosmetic Medicine (AACM) offers one of the best online filler course for licensed healthcare professionals. The self-paced program costs $299 plus tax and provides 8.5 accredited CME hours, giving eligible providers a structured way to study injectable treatments on their own schedule. The activity is jointly provided by AACM and the Postgraduate Institute for Medicine (PIM), which holds joint accreditation from the...

Read more

GeBBS Healthcare Solutions Ranked #1 in Black Book's 2026 Technology-Enabled Coding-to-Cash RCM Managed Operations Study

September 28, 2026 10:00 AM

Black Book Research announced today that GeBBS Healthcare Solutions ranked #1 overall in client satisfaction for Technology-Enabled Coding-to-Cash RCM Managed Operations in its 2026 comparative vendor performance study. The Black Book evaluation included 1,176 validated provider-side revenue cycle users and executives, 20 revenue cycle management vendors and 18 category-specific key performance indicators measuring technology-enabled managed...

Read more

HCAA Expands Access to Certified Self Funding Specialist(R) Designation Through WebCE

September 28, 2026 9:50 AM

The Health Care Administrators Association (HCAA), the nation's leading nonprofit membership trade association supporting the self-funded health benefits industry, is offering its Certified Self Funding Specialist® (CSFS®) designation through WebCE, providing insurance and benefits professionals with a convenient way to expand their knowledge of self-funded healthcare while earning continuing education credits. Designed for professionals who...

Read more

Rabies Prevention: From Ancient Fear to Modern Solutions

September 28, 2026 9:35 AM

Rabies is one of humanity's oldest known zoonotic diseases: terrifying, yet entirely preventable. For Dr. Andre Coetzer, a virologist leading GARC- Rabies Alliance (GARC), the journey began as an academic fascination and became a personal mission. Working in resource-limited communities across Africa and Asia, he has seen the fear rabies causes, as well as the needless loss that follows when solutions, especially dog vaccinations and rapid...

Read more

Senzime Strengthens Financing to Support Strategic OEM Expansion and Path to Profitability

September 28, 2026 9:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has strengthened its financing structure through a new SEK 35 million non-dilutive credit facility with a group of institutional investors, including the Segulah and Crafoord groups. The credit facility replaces Senzime's previously communicated credit line arrangement and extends the company's existing credit financing on improved terms, without increasing the total credit...

Read more

CVS Health Is Making a Difference in Local Communities, One Classroom at a Time

September 28, 2026 9:00 AM

Originally published on CVS Health Company Newsroom When students and teachers return to the classroom, having the right supplies can make a meaningful difference. This year, CVS Health and Aetna teamed up with community organizations and some of our sports partners - The Washington Spirit, Kansas City Current and the Boston Red Sox - to help students and their families start the school year with the resources, confidence, and support they need...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Advances Internal Testing of Its AI Wound-Monitoring Application

September 28, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced forward progress on its AI wound-monitoring application, advancing the platform from a development-track mention into structured internal evaluation of sequential wound imaging. The update follows a year in which MDCE has publicly treated wound monitoring as a second health-imaging line beside Melanoma Scan Beta. On July 20, the Company positioned its AI vision platform against the...

Read more

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

September 28, 2026 8:45 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and other Ebola viruses in the Democratic Republic of Congo ("DRC") has started enrolling and dosing patients at an Ebola Treatment Center in the Ituri province. This clinical trial is...

Read more

Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

September 28, 2026 8:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that the contract manufacturing ("CMO") pipeline of its wholly owned subsidiary, Cana Laboratories S.A. ("Cana"), has surpassed $20 million in implied revenue over the life of the underlying agreements, representing over $18 million in implied gross profit at gross margins of over 90%, as the...

Read more

Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa

September 28, 2026 7:29 AM

Francis Kwoba is a 68-year-old retired policeman from Bungoma County, Kenya. During one of his usual morning runs, he experienced a sudden sharp pain in his chest. Concerned by the symptoms, he sought medical attention at the nearest health facility and was prescribed an anti-tuberculosis medication for treatment. After three months, Francis's chest pain persisted and he began experiencing breathlessness. At Moi Teaching and Referral Hospital...

Read more

Global IP Thought Leaders, Scholars, and Policymakers to Gather in Paris for "Competing for the Cure" Conference on Biopharmaceutical Ecosystems

September 28, 2026 7:00 AM

On October 29-30, 2026, the Berkeley Policy Institute's Eira Initiative will host a major international conference titled "Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems" at the Maison de l'Amérique Latine in Paris. The two-day event will bring together top economists, legal scholars, industry leaders, and policy architects in the life sciences to present ground-breaking empirical and policy...

Read more

DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application

September 28, 2026 6:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, and Tollo Health, LLC ("Tollo"), a healthcare company commercializing proprietary medical foods and dietary supplements and, through TolloBio, developing biopharmaceutical candidates,...

Read more

XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System

September 28, 2026 5:20 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announced that the U.S. Food and Drug Administration (FDA) has received the Premarket Approval (PMA) application for the XVIVO Heart Assist Transport System. The application is supported by clinical data from the PRESERVE IDE trial, as well as additional evidence from the PRESERVE Continued Access Protocol (CAP) trial and clinical experience outside the United States. The PRESERVE...

Read more